Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity, Drug”

443 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 443 results

Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29
Post-approval studies (Phase 4)Study completedNCT02509312
What this trial is testing

Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

Who this might be right for
Analgesia, ObstetricalPostpartum HemorrhageOpioid Use+5 more
University Hospitals Cleveland Medical Center 70
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableNot Yet RecruitingNCT03969693
What this trial is testing

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Who this might be right for
Mediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma
Chang Gung Memorial Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableUnknownNCT04461392
What this trial is testing

Exercise Response After Revalidation in Cancer Patients

Who this might be right for
OncologyCardiac Toxicity
Universitair Ziekenhuis Brussel 191
Large-scale testing (Phase 3)UnknownNCT06152471
What this trial is testing

Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer

Who this might be right for
Early-stage Breast CancerDiarrheaAdverse Drug Event
Henrik Lindman 100
Not applicableStudy completedNCT05358132
What this trial is testing

ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity

Who this might be right for
Respiratory InsufficiencyOverdose of OpiateSedative Overdose+1 more
NHS Greater Glasgow and Clyde 78
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Not applicableUnknownNCT03469063
What this trial is testing

Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients

Who this might be right for
Quality of LifeInfectionDrug Toxicity
Barretos Cancer Hospital 104
Post-approval studies (Phase 4)Study completedNCT01641458
What this trial is testing

Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients

Who this might be right for
Colorectal Cancer
Cantonal Hospital of St. Gallen 37
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Not applicableStudy completedNCT03113136
What this trial is testing

Examination of Low Wattage and High Wattage E-Cigarettes

Who this might be right for
Smoking, CigaretteSmoking, TobaccoNicotine Dependence+1 more
Ohio State University Comprehensive Cancer Center 372
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Not applicableEnrolling By InvitationNCT07473271
What this trial is testing

Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Rehabilitation Therapy in Pelvic Radiotherapy

Who this might be right for
Indicated for Pelvic Radiotherapy, Vaginal Rehabilitation, and Alleviation of Late Toxic Reactions in the Vagina
Peking Union Medical College Hospital 76
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Not applicableStudy completedNCT01038284
What this trial is testing

Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
University Hospital, Grenoble 101
Load More Results